Abstract
The efficient analysis and interpretation of high throughput molecular genomics data are contingent upon reliable and current evidence-based resources. Gene lists to identify regions of diagnostic, prognostic, or therapeutic importance have become integral in the analysis of many clinical genomic tests, including chromosomal/SNP microarrays, NGS (Next Generation Sequencing) panels, and targeted whole exome/genome sequencing. Two Cancer Genomics Consortium (CGC) working groups in collaboration with the Mayo Clinic Genomics of Oncology Annotation Team (GOAT) have curated myeloid neoplasms and breast cancer gene lists with vetted annotation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
